Literature DB >> 8379231

[Qualitative and semiquantitative invasive and noninvasive diagnosis of Helicobacter pylori colonization of gastric mucosa].

J Labenz1, M Stolte, S Aygen, O Hennemann, J Bertrams, G Börsch.   

Abstract

In 110 patients with unknown Helicobacter pylori status and without anti-bacterial treatment submitted for routine endoscopy of the upper gastrointestinal tract biopsies were taken from the antral and body mucosa, which were assessed for H. pylori colonisation and/or gastritis by an urease test (Jatrox H. p.-Test), microscopy after methylene-blue staining of a mucosal smear, specific culture and histology (stains: haematoxylin & eosin and Warthin-Starry). In addition, a simplified 13C-urea breath test was validated. A complete set of data was available from 104 patients (64 women - 40 men, median of age: 55 years [range: 17-92 years], H. pylori positive histologically and/or culturally [goldstandard]: n = 67). The test criteria sensitivity, specificity, positive and negative predictive value were calculated to be 100%/100%/100%/100% for the urease test, 76.1%/100%/100%/69.8% for microscopy of a mucosal smear, and 92.5%/97.3%/98.4%/88.1% for 13C-urea breath test (two-point measurement). Statistical analysis demonstrated highly significant (p < 0.0001) correlations between the reaction velocity of the urease test, the histologically visible degree of Helicobacter pylori colonisation and the differences of the delta-values of the 13C-urea breath test on the one hand and between grade and activity of gastritis as well as between the gastritis and activity scores, respectively, and the semi-quantitatively categorized results of the urease test, the histological degree of H. pylori colonisation and the 13C-urea breath test on the other hand.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379231

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  8 in total

1.  Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.

Authors:  J Labenz; B Tillenburg; U Peitz; E Verdú; M Stolte; G Börsch; A L Blum
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection.

Authors:  J E Domínguez-Muñoz; A Leodolter; T Sauerbruch; P Malfertheiner
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

3.  Eradication rate of Helicobacter pylori.

Authors:  J Labenz; B Tillenburg; U Peitz; H Köhl; G Börsch
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

4.  Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.

Authors:  J Labenz; U Peitz; C Leusing; B Tillenburg; A L Blum; G Börsch
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

5.  Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms.

Authors:  B Braden; W F Caspary; B Lembcke
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

6.  Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.

Authors:  J Labenz; M Stolte; A L Blum; I Jorias; F Leverkus; M Sollböhmer; J Bertrams; G Börsch
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

7.  Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans.

Authors:  Heidrun Mehling; Andreas Busjahn
Journal:  Nutrients       Date:  2013-08-02       Impact factor: 5.717

8.  Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study.

Authors:  Caterina Holz; Andreas Busjahn; Heidrun Mehling; Stefanie Arya; Mewes Boettner; Hajar Habibi; Christine Lang
Journal:  Probiotics Antimicrob Proteins       Date:  2015-06       Impact factor: 4.609

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.